Management of Refractory Epilepsy

作者: Karen R Muñana

DOI: 10.1053/J.TCAM.2013.06.007

关键词:

摘要: The term refractory epilepsy is utilized in veterinary medicine to describe a condition which an animal with fails attain satisfactory seizure control or suffers intolerable side effects despite appropriate therapy conventional antiepileptic drugs. Refractory important problem small practice as it occurs approximately one-third of dogs epilepsy. Consequently, there much interest identifying ways more effectively treat this population animals. More than dozen new drugs have been approved for humans over the last 2 decades, and several these drugs, including gabapentin, zonisamide, levetiracetam, pregabalin, evaluated treatment seizures patients. Nonmedical methods poorly controlled are also being explored. alternative forms that shown most promise electrical stimulation brain dietary modification, both dogs. This overview summarizes available data on pharmacologic well nonmedical options cats Although many currently clinical practice, our knowledge safety efficacy treatments limited. Additional randomized trials needed better evaluate novel therapies cats.

参考文章(47)
J E Stahlbrodt, J Speciale, Use of ocular compression to induce vagal stimulation and aid in controlling seizures in seven dogs. Javma-journal of The American Veterinary Medical Association. ,vol. 214, pp. 663- 665 ,(1999)
Sarah Anne Moore, KR Munana, MG Papich, JA Nettifee‐Osborne, The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital Journal of Veterinary Pharmacology and Therapeutics. ,vol. 34, pp. 31- 34 ,(2011) , 10.1111/J.1365-2885.2010.01188.X
H. M. WRIGHT, A. V. CHEN, S. E. MARTINEZ, N. M. DAVIES, Pharmacokinetics of oral rufinamide in dogs. Journal of Veterinary Pharmacology and Therapeutics. ,vol. 35, pp. 529- 533 ,(2012) , 10.1111/J.1365-2885.2011.01353.X
L. L. Radulovic, K. O. Vollmer, D. Türck, B. J. Hanson, P. D. Dehart, A. Von Hodenberg, W. P. Mcnally, Tsun Chang, H. N. Bockbrader, Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metabolism and Disposition. ,vol. 23, pp. 441- 448 ,(1995)
Velia-Isabel Hülsmeyer, Andrea Fischer, Paul J.J. Mandigers, Luisa DeRisio, Mette Berendt, Clare Rusbridge, Sofie F.M. Bhatti, Akos Pakozdy, Edward E. Patterson, Simon Platt, Rowena M.A. Packer, Holger A. Volk, International Veterinary Epilepsy Task Force's current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs BMC Veterinary Research. ,vol. 11, pp. 175- 175 ,(2015) , 10.1186/S12917-015-0463-0
J Penderis, L S Garosi, C J Abramson, S R Platt, V Adams, A De Stefani, L Matiasek, Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Veterinary Record. ,vol. 159, pp. 881- 884 ,(2006) , 10.1136/VR.159.26.881
Patrick Kwan, Alexis Arzimanoglou, Anne T. Berg, Martin J. Brodie, W. Allen Hauser, Gary Mathern, Solomon L. Moshé, Emilio Perucca, Samuel Wiebe, Jacqueline French, Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. ,vol. 51, pp. 1069- 1077 ,(2009) , 10.1111/J.1528-1167.2009.02397.X
G SILLS, The mechanisms of action of gabapentin and pregabalin Current Opinion in Pharmacology. ,vol. 6, pp. 108- 113 ,(2006) , 10.1016/J.COPH.2005.11.003
Wolfgang Löscher, Heidrun Potschka, Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs Journal of Pharmacology and Experimental Therapeutics. ,vol. 301, pp. 7- 14 ,(2002) , 10.1124/JPET.301.1.7
M.L. Miller, S.A. Center, J.F. Randolph, M.L. Lepherd, M.A. Cautela, C.W. Dewey, Apparent acute idiosyncratic hepatic necrosis associated with zonisamide administration in a dog. Journal of Veterinary Internal Medicine. ,vol. 25, pp. 1156- 1160 ,(2011) , 10.1111/J.1939-1676.2011.00783.X